Please confirm you are human (Sign Up for free to never see this)
← Back to Search
Emerging Therapies To Prevent Post-ERCP Pancreatitis
N. Thiruvengadam, M. Kochman
Published 2020 · Medicine
Save to my Library
Download PDFAnalyze on Scholarcy
The aim of this review is to evaluate emerging, novel therapies for the prevention of post-ERCP pancreatitis. Rectal indomethacin reduces the risk of pancreatitis in low- and average-risk patients, who comprise the majority of patients undergoing ERCP. An 8-h protocol of aggressive lactated Ringer’s reduces the risk of pancreatitis in average-risk patients. Sublingual nitrate may provide additional benefit to rectal NSAIDs in preventing PEP. A tacrolimus trough > 2.5 ng/mL was recently shown to be associated with a lower risk of PEP in liver transplant patients undergoing ERCP. Routine usage of rectal indomethacin in all patients undergoing ERCP reduces the risk of PEP. Pancreatic-duct stents reduce the risk of PEP in high-risk patients. There is emerging data that aggressive hydration with lactated Ringer’s and nitrates may further reduce PEP. Tacrolimus is a promising potential agent to prevent PEP but needs further clinical study.
This paper references
Deletion of IκBα activates RelA to reduce acute pancreatitis in mice through up-regulation of Spi2A.
P. Neuhoefer (2013)
Complications of diagnostic and therapeutic ERCP: a prospective multicenter study
E. Masci (2001)
Gabexate or somatostatin administration before ERCP in patients at high risk for post-ERCP pancreatitis: a multicenter, placebo-controlled, randomized clinical trial.
A. Andriulli (2002)
449 Blood Urea Nitrogen as a Predictor of Development of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis: A Case- Control Study
T. Kushner (2012)
Incidence, severity, and mortality of postERCP pancreatitis: a systematic review by using randomized, controlled trials. Gastrointest Endosc
B Kochar (2014)
Prophylaxis of post-ERCP pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - updated June 2014.
J. Dumonceau (2014)
Does prophylactic pancreatic stent placement reduce the risk of post-ERCP acute pancreatitis? A meta-analysis of controlled trials.
P. Singh (2004)
Combination pharmacoprophylaxis for post-ERCP pancreatitis: working toward an evidence base.
B. Elmunzer (2017)
Serum amylase measured four hours after endoscopic sphincterotomy is a reliable predictor of postprocedure pancreatitis
P. Testoni (1999)
Intraductal acidosis in acute biliary pancreatitis.
T. Takács (2013)
Intravenous bolus somatostatin after diagnostic cholangiopancreatography reduces the incidence of pancreatitis associated with therapeutic endoscopic retrograde cholangiopancreatography procedures: a randomised controlled trial
R. Poon (2003)
This randomized controlled trial demonstrated that there was no additional benefit in reducing PEP with topical epinphephrine when added to rectal indomethacin when compared to rectal
A Kamal (2019)
Deletion of IkappaBalpha activates RelA to reduce acute pancreatitis in mice through up-regulation of Spi2A
P Neuhofer (2012)
Early Measures of Hemoconcentration and Inflammation Are Predictive of Prolonged Hospitalization From Post– Endoscopic Retrograde Cholangiopancreatography Pancreatitis
G. Coté (2013)
Evidence for involvement of NF-kappaB in the transcriptional control of COX-2 gene expression by IL-1beta.
R. Newton (1997)
Incidence, severity, and mortality of post-ERCP pancreatitis: a systematic review by using randomized, controlled trials.
B. Kochar (2015)
Effect of glyceryl trinitrate on the sphincter of Oddi motility and baseline pressure.
M. Staritz (1985)
Meta-analysis of prophylactic corticosteroid use in post-ERCP pancreatitis
M. Zheng (2008)
The updated ASGE guidelines recommend rectal indomethacin usage in high-risk patients
• Committee Asop (2017)
A comparison of nonionic versus ionic contrast media: results of a prospective, multicenter study. Midwest Pancreaticobiliary Study Group.
G. K. Johnson (1995)
Nafamostat Mesilate for Prevention of Post-ERCP Pancreatitis: A Meta-analysis of Prospective, Randomized, Controlled Trials
Ge Yu (2015)
Prophylaxis of ERCP-related pancreatitis: a randomized, controlled trial of somatostatin and gabexate mesylate.
A. Andriulli (2004)
The role of cytokines in the pathogenesis of acute pancreatitis.
J. Norman (1998)
Doubleguidewire technique in difficult biliary cannulation for the prevention of post-ERCP pancreatitis: a systematic review and meta-analysis. Endoscopy
F Tse (2017)
Low-osmolality contrast media: a current perspective.
B. King (1989)
Nifedipine for prevention of post-ERCP pancreatitis: a prospective, double-blind randomized study.
F. Prat (2002)
Exposure to Radiocontrast Agents Induces Pancreatic Inflammation by Activation of Nuclear Factor-κB, Calcium Signaling, and Calcineurin.
S. Jin (2015)
Prophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis by an endoscopic n t . C l i n
A Sofuni (2007)
Interaction of calcineurin with substrates and targeting proteins.
Huiming Li (2011)
Endoscopic sphincterotomy complications and their management: an attempt at consensus.
P. Cotton (1991)
Prophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis by an endoscopic pancreatic spontaneous dislodgement stent.
A. Sofuni (2007)
Reducing extracellular pH sensitizes the acinar cell to secretagogue-induced pancreatitis responses in rats.
Madhavi Bhoomagoud (2009)
Nonsteroidal antiinflammatory drugs for prevention of post-ERCP pancreatitis: a meta-analysis
X Ding (2012)
Double-guidewire technique in difficult biliary cannulation for the prevention of post-ERCP pancreatitis: a systematic review and meta-analysis.
F. Tse (2017)
Complications of endoscopic biliary sphincterotomy.
Z. Tulassay (1997)
Routine pre-procedural rectal indometacin versus selective post-procedural rectal indometacin to prevent pancreatitis in patients undergoing endoscopic retrograde cholangiopancreatography: a multicentre, single-blinded, randomised controlled trial
H. Luo (2016)
Endoscopic sphincterotomy-induced pancreatitis: increased risk associated with nondilated bile ducts and sphincter of Oddi dysfunction.
Y. Chen (1994)
Effect of somatostatin on prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis and hyperamylasemia: A systematic review and meta-analysis.
Guiliang Wang (2018)
The acinar cell and early pancreatitis responses.
F. Gorelick (2009)
Aggressive Hydration With Lactated Ringer Solution in Prevention of Postendoscopic Retrograde Cholangiopancreatography Pancreatitis: A Meta-analysis of Randomized Controlled Trials
Z. Zhang (2017)
Pancreatic interstitial pH regulation: effects of secretory stimulation.
S. Ashley (1994)
Esterase inhibitors prevent lysosomal enzyme redistribution in two noninvasive models of experimental pancreatitis.
G. Ohshio (1989)
Rectal Indomethacin Is Protective against Pancreatitis after Endoscopic Retrograde Cholangiopancreatography: Systematic Review and Meta-Analysis
Xingkang He (2018)
Molecular basis for pancreatitis
E. Thrower (2008)
Meta-analysis: allopurinol in t h e p r e v e n t i o n o f p o s t e n d o s c o p i c r e t r o g r a d e cholangiopancreatography pancreatitis
Y Bai (2008)
Indomethacin May Reduce the Incidence and Severity of Acute Pancreatitis After ERCP
R. Sotoudehmanesh (2007)
Lactic and hydrochloric acids induce different patterns of inflammatory response in LPS-stimulated RAW 264.7 cells.
J. Kellum (2004)
a d e cholangiopancreatography procedures: a randomised controlled trial
R T Poon (2003)
Post-endoscopic retrograde cholangiopancreatography pancreatitis. Gastroenterol Rep (Oxf)
A M Thaker
Post-endoscopic retrograde cholangiopancreatography pancreatitis
V. Singh (2016)
Intracellular vacuoles in experimental acute pancreatitis in rats and mice are an acidified compartment.
C. Niederau (1988)
Regulation of acinar cell function in the pancreas
J. Williams (2010)
Meta‐analysis: allopurinol in the prevention of postendoscopic retrograde cholangiopancreatography pancreatitis
Y. Bai (2008)
The role of glucagon in endoscopic cholangiopancreatography.
S. Silvis (1975)
Rectal Indomethacin and Spraying of Duodenal Papilla With Epinephrine Increases Risk of Pancreatitis Following Endoscopic Retrograde Cholangiopancreatography.
H. Luo (2019)
Low-dose heparin for the prevention of post-ERCP pancreatitis: a randomized placebo-controlled trial
O. Barkay (2007)
Evidence for Involvement of NF-κB in the Transcriptional Control of COX-2 Gene Expression by IL-1β ☆
R. Newton (1997)
Tacrolimus and Indomethacin are Safe and Effective at Reducing Pancreatitis After Endoscopic Retrograde Cholangiopancreatography in Patients Who Have Undergone Liver Transplantation.
N. Thiruvengadam (2019)
Chloroquine Stabilizes Pancreatic Lysosomes and Improves Survival of Mice with Diet‐Induced Acute Pancreatitis
S. Guillaumes (1997)
Post-ERCP pancreatitis and hyperamylasemia: patient-related and operative risk factors.
E. Christoforidis (2002)
Effect of microcirculatory perfusion on distribution of trypsinogen activation peptides in acute experimental pancreatitis
T. Foitzik (2005)
Prevention of post‐endoscopic retrograde cholangiopancreatography pancreatitis by epinephrine sprayed on the papilla
L. Xu (2011)
Epinephrine sprayed on the papilla for prevention of post-ERCP pancreatitis
Mitsunobu Matsushita (2008)
Early Precut Sphincterotomy Does Not Increase Risk During Endoscopic Retrograde Cholangiopancreatography in Patients With Difficult Biliary Access: A Meta-analysis of Randomized Controlled Trials.
P. Sundaralingam (2015)
Comparative efficacy of 9 m a j o r d r u g s f o r p o s t e n d o s c o p i c r e t r o g r a d e cholangiopancreatography pancreatitis: a network meta-analysis
Y Lyu (2019)
Presence of Cathepsin B in the Human Pancreatic Secretory Pathway and Its Role in Trypsinogen Activation during Hereditary Pancreatitis*
Z. Kukor (2002)
A Nonpancreatic Source of the Proteolytic‐enzyme Amidase and Bacteriology in Experimental Acute Pancreatitis
W. M. Keynes (1980)
Aggressive hydration with lactated Ringer's solution reduces pancreatitis after endoscopic retrograde cholangiopancreatography.
J. Buxbaum (2014)
Pancreatic stents for prophylaxis against post-ERCP pancreatitis: a meta-analysis and systematic review.
A. Choudhary (2011)
Vigorous Periprocedural Hydration With Lactated Ringer's Solution Reduces the Risk of Pancreatitis After Retrograde Cholangiopancreatography in Hospitalized Patients
J. Choi (2017)
Activation of nuclear factor-κB in acinar cells increases the severity of pancreatitis in mice.
H. Huang (2013)
Influence of Chloroquine on Diet‐Induced Pancreatitis
S. Leach (1993)
This retrospective cohort study of 337 liver transplant patients undergoing ERCP demonstrated that a tacrolimus trough level > 2.5 ng/mL was significantly associated with lower rates of PEP
N R •• Thiruvengadam (2020)
The effect of lactate-buffered solutions on the acid-base status of patients with renal failure.
A. Davenport (1989)
A pH-sensitive, neurogenic pathway mediates disease severity in a model of post-ERCP pancreatitis
M. Noble (2008)
Pancreatic outflow obstruction as the critical event for human gall stone induced pancreatitis.
M. Lerch (1994)
A Randomized Trial of Topical Epinephrine and Rectal Indomethacin for Preventing Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis in High-Risk Patients
A. Kamal (2019)
Prophylaxis of post-ERCP pancreatitis: a practice survey.
J. Dumonceau (2010)
Kinetic study of TNF‐α production and its regulatory mechanisms in acinar cells during acute pancreatitis induced by bile–pancreatic duct obstruction
L. Ramudo (2005)
Can a Wire-Guided Cannulation Technique Increase Bile Duct Cannulation Rate and Prevent Post-ERCP Pancreatitis?: A Meta-Analysis of Randomized Controlled Trials
V. Cennamo (2009)
Effect of Camostate Administration for Two Weeks on Experimental Pancreatitis in Mice and Rats
U. Leonhardt (1993)
Does leaving a main pancreatic duct stent in place reduce the incidence of precut biliary sphincterotomy-associated pancreatitis? A randomized, prospective study.
Sang-Woo Cha (2013)
Adverse events associated with ERCP.
V. Chandrasekhara (2017)
Trypsin Stimulates Production of Cytokines from Peritoneal Macrophages In Vitro and In Vivo
A. H. Lundberg (2000)
Pancreatic Ischemia Associated With Vasospasm in the Early Phase of Human Acute Necrotizing Pancreatitis
K. Takeda (2005)
IL-6 trans-signaling promotes pancreatitis-associated lung injury and lethality.
H. Zhang (2013)
Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations
Risk Factors for Post-ERCP Pancreatitis: A Prospective Multicenter Study
Chi-Liang Cheng (2006)
Decreased Mortality of Severe Acute Pancreatitis After Proximal Cytokine Blockade
J. Norman (1995)
Interleukin-1 receptor antagonist decreases severity of experimental acute pancreatitis.
J. Norman (1995)
Stent placement in the pancreatic duct prevents pancreatitis after endoscopic sphincter dilation for removal of bile duct stones.
T. Aizawa (2001)
Prospective randomized double-blind placebo-controlled trial of glyceryl trinitrate in endoscopic retrograde cholangiopancreatography
Does a pancreatic duct stent prevent post-ERCP pancreatitis? A prospective randomized study.
A. Fazel (2003)
Endoscopic management of tumors of the major duodenal papilla: Refined techniques to improve outcome and avoid complications.
D. Desilets (2001)
Exocytosis occurs at the lateral plasma membrane of the pancreatic acinar cell during supramaximal secretagogue stimulation.
G. Scheele (1987)
Risk factors for complications after performance of ERCP.
J. Vandervoort (2002)
Transient High Pressure in Pancreatic Ducts Promotes Inflammation and Alters Tight Junctions via Calcineurin Signaling in Mice.
L. Wen (2018)
Lowdose heparin for the prevention of post-ERCP pancreatitis: a randomized placebo-controlled trial
O Barkay (2008)
A randomized trial of rectal indomethacin to prevent post-ERCP pancreatitis.
B. Elmunzer (2012)
Risk factors for pancreatitis following endoscopic retrograde cholangiopancreatography: a meta-analysis.
E. Masci (2003)
Effects of bolus somatostatin in preventing pancreatitis after endoscopic pancreatography: results of a randomized study.
J. Bordas (1998)
Prospective randomized double-blind placebo-controlled trial of glyceryl trinitrate in endoscopic retrograde cholangiopancreatography-induced pancreatitis.
M. Moretó (2002)
Cyclooxygenase-2 gene disruption attenuates the severity of acute pancreatitis and pancreatitis-associated lung injury.
R. Ethridge (2002)
Somatostatin and somatostatin analogues--are they indicated in the management of acute pancreatitis?
C. Mckay (1993)
Rectal Indomethacin Reduces Pancreatitis in High- and Low-Risk Patients Undergoing Endoscopic Retrograde Cholangiopancreatography.
N. Thiruvengadam (2016)
Relationship between post-ERCP pancreatitis and the change of serum amylase level after the procedure.
K. Ito (2007)
Prophylactic effect of glyceryl trinitrate on post-endoscopic retrograde cholangiopancreatography pancreatitis: a randomized placebo-controlled trial.
J. Y. Hao (2009)
Combination of Diclofenac and Sublingual Nitrates Is Superior to Diclofenac Alone in Preventing Pancreatitis After Endoscopic Retrograde Cholangiopancreatography.
T. Tomoda (2019)
Pancreatic duct guidewire placement for biliary cannulation in a single-session therapeutic ERCP.
D. Xinopoulos (2011)
Comparative Efficacy of 9 Major Drugs for Postendoscopic Retrograde Cholangiopancreatography Pancreatitis: A Network Meta-Analysis
Yunxiao Lyu (2019)
Pancreatic stenting prevents pancreatitis after biliary sphincterotomy in patients with sphincter of Oddi dysfunction.
P. Tarnasky (1998)
Fluid resuscitation with lactated Ringer’s solution vs normal saline in acute pancreatitis: A triple-blind, randomized, controlled trial
E. de-Madaria (2018)
Effect of ethanol on pancreatic interstitial pH and blood flow in cats with chronic pancreatitis.
M. Toyama (1997)
Exposure to radiocontrast agents induces pancreatic inflammation by activation of nuclear factor-kappaB, calcium signaling, and calcineurin. Gastroenterology
S Jin (2015)
Nonsteroidal anti-inflammatory drugs for prevention of post-ERCP pancreatitis: a meta-analysis.
Xiwei Ding (2012)
Rectal Indomethacin Does Not Prevent Post-ERCP Pancreatitis in Consecutive Patients.
J. Levenick (2016)